NCT03710603 2026-02-10PerseusEuropean Myeloma Network B.V.Phase 3 Active not recruiting709 enrolled 17 charts 1 FDA
NCT04258943 2025-09-18Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid LeukemiaChildren's Oncology GroupPhase 1/2 Active not recruiting60 enrolled 1 FDA